Isolated seizures are a common early feature of paraneoplastic anti-GABA
Aged
Aged, 80 and over
Amnesia, Anterograde
/ etiology
Autoantibodies
/ cerebrospinal fluid
Encephalitis
/ diagnosis
Female
Humans
Immunotherapy
Lung Neoplasms
/ complications
Male
Middle Aged
Paraneoplastic Syndromes, Nervous System
/ diagnosis
Receptors, GABA-B
/ immunology
Retrospective Studies
Seizures
/ diagnosis
Small Cell Lung Carcinoma
/ complications
Epilepsy
GABAB receptor autoantibodies
Paraneoplatic neurological syndromes
Small cell lung cancer
Status epilepticus
Journal
Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
19
09
2018
accepted:
16
11
2018
revised:
21
10
2018
pubmed:
22
11
2018
medline:
8
5
2019
entrez:
22
11
2018
Statut:
ppublish
Résumé
To report the clinical features and long-term outcome of 22 newly diagnosed paraneoplastic patients with GABA Retrospective clinical study of CSF-confirmed cases of GABA We identified 22 patients (4 female) with GABA Paraneoplastic GABA
Identifiants
pubmed: 30460450
doi: 10.1007/s00415-018-9132-0
pii: 10.1007/s00415-018-9132-0
doi:
Substances chimiques
Autoantibodies
0
Receptors, GABA-B
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
195-206Subventions
Organisme : Agence Nationale de la Recherche
ID : ANR-14-CE15-0001-MECANO
Organisme : Fédération pour la Recherche sur le Cerveau
ID : FRC-Neurodon2014
Organisme : Fondation pour la recherche médicale
ID : DQ20170336751
Références
PLoS One. 2016 Feb 05;11(2):e0148800
pubmed: 26848590
Brain. 2016 Apr;139(Pt 4):1079-93
pubmed: 26945884
Eur J Neurosci. 2007 May;25(10):2982-90
pubmed: 17561812
Neuropsychopharmacology. 2004 Jun;29(6):1050-62
pubmed: 15039762
Curr Treat Options Neurol. 2011 Jun;13(3):324-32
pubmed: 21298406
Int J Neurosci. 2017 May;127(5):379-385
pubmed: 27066808
Neurology. 2017 Feb 7;88(6):514-524
pubmed: 28062719
Lancet Neurol. 2010 Jan;9(1):67-76
pubmed: 19962348
Neurol Neuroimmunol Neuroinflamm. 2016 Apr 29;3(3):e232
pubmed: 27213174
Neurology. 2011 Mar 1;76(9):795-800
pubmed: 21357831
Lancet Neurol. 2016 Apr;15(4):391-404
pubmed: 26906964
Epileptic Disord. 2014 Dec;16(4):486-93
pubmed: 25465280
Neurology. 2008 Sep 16;71(12):930-6
pubmed: 18794496
Lancet Neurol. 2013 Feb;12(2):157-65
pubmed: 23290630
Neurology. 2013 Sep 3;81(10):882-7
pubmed: 23925760
Ann Neurol. 2011 May;69(5):892-900
pubmed: 21416487
J Neuroimmunol. 2013 Jun 15;259(1-2):88-91
pubmed: 23628208
Neurology. 2012 Feb 21;78(8):578-84
pubmed: 22351795
J Neuroimmunol. 2015 Oct 15;287:31-5
pubmed: 26439959
J Neurol Neurosurg Psychiatry. 2015 Sep;86(9):965-72
pubmed: 25300449
Mol Cell Neurosci. 2001 Jun;17(6):1059-70
pubmed: 11414794
J Neuroimmunol. 2014 Jul 15;272(1-2):91-3
pubmed: 24814391
Neurology. 2013 Oct 22;81(17):1500-6
pubmed: 24068784
Neurosci Biobehav Rev. 2016 Apr;63:1-28
pubmed: 26814961
J Neuroimmunol. 2013 Mar 15;256(1-2):94-6
pubmed: 23332614
Stroke. 2009 Oct;40(10):3393-5
pubmed: 19679846
J Neurosci. 2010 Oct 20;30(42):14194-204
pubmed: 20962240
Neuron. 2006 May 18;50(4):589-601
pubmed: 16701209
Neuron. 2001 Jul 19;31(1):47-58
pubmed: 11498050
Neurology. 2003 Feb 25;60(4):560-3
pubmed: 12601092
Neurology. 1998 Oct;51(4):1146-50
pubmed: 9781545